Banque Pictet & Cie’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-5,159
Closed -$93.3K – 367
2026
Q1
$93.3K Sell
5,159
-9,343
-64% -$178K ﹤0.01% 380
2025
Q4
$315K Buy
+14,502
New +$415K ﹤0.01% 353

Other funds holding LEGN

Banque Pictet & Cie's LEGN Position: Q2 2026 in Review

Banque Pictet & Cie sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 5,159 shares — an estimated $93.3K sold.

Banque Pictet & Cie first reported a position in LEGN in Q4 2025 and held it in 2 quarters. The position peaked at $315K in Q4 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Banque Pictet & Cie reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Banque Pictet & Cie sold 5,159 Legend Biotech shares in Q2 2026, an estimated $93.3K.
  • Banque Pictet & Cie first reported a position in Legend Biotech in Q4 2025 and held it in 2 quarters.
  • Banque Pictet & Cie's Legend Biotech position peaked at $315K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.